Therapeutic regimens
First Claim
Patent Images
1. A unit dosage form suitable for once daily administration to a human subject in need thereof comprising 0.9 mg to 1.1 mg, 2.2 mg to 2.8 mg, 4.4 mg to 5.6 mg, or 9 mg to 11 mg of the compound of formula I as its dihydrochloride salt
10 Assignments
0 Petitions
Accused Products
Abstract
This invention relates to clinically useful therapeutic regimens comprising the administration of (R)-6-(2-(ethyl(4-(2-(ethylamino)ethyl)benzyl)amino)-4-methoxyphenyl)-5,6,7,8-tetrahydronaphthalen-2-ol.
-
Citations
36 Claims
- 1. A unit dosage form suitable for once daily administration to a human subject in need thereof comprising 0.9 mg to 1.1 mg, 2.2 mg to 2.8 mg, 4.4 mg to 5.6 mg, or 9 mg to 11 mg of the compound of formula I as its dihydrochloride salt
- 4. A unit dosage form comprising 0.9 mg to 1.1 mg, 2.2 mg to 2.8 mg, 4.4 mg to 5.6 mg, or 9 mg to 11 mg of the compound of formula I or a salt thereof
- 6. A method of treating vasomotor disturbances in a peri-menopausal or postmenopausal woman in need thereof comprising administering to the woman a composition comprising a compound of formula I or a salt thereof
- 11. A method of treating vasomotor disturbances in a peri-menopausal or postmenopausal woman in need thereof comprising administering to the woman a compound of formula I or a salt thereof
- 19. A method of treating vasomotor disturbances in a peri-menopausal or postmenopausal woman in need thereof comprising administering to the woman a compound of formula I or a salt thereof
Specification